IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
2.15
0.87 (67.97%)
At close: Aug 15, 2025, 3:59 PM
2.02
-6.11%
After-hours: Aug 15, 2025, 07:01 PM EDT
67.97% (1D)
| Bid | 1.96 |
| Market Cap | 141.64M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -98.45M |
| EPS (ttm) | -1.49 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | -1.65 |
| Analyst | Buy |
| Ask | 2.09 |
| Volume | 35,240,757 |
| Avg. Volume (20D) | 2,060,717 |
| Open | 1.40 |
| Previous Close | 1.28 |
| Day's Range | 1.33 - 2.21 |
| 52-Week Range | 0.66 - 2.48 |
| Beta | 0.44 |
About IOBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IOBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IOBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts22 hours ago
IO Biotech shares are trading higher following the...
Unlock content with
Pro Subscription
4 days ago
-41.99%
Shares are trading lower after the company said its Phase 3 trial of Cylembio plus Keytruda in advanced melanoma narrowly missed the primary endpoint.
